Hamlet BioPharma is pleased to announce the continuation of the digital event series in the spring of 2025. These events provide participants a valuable opportunity to follow and discuss our drug development process and engage directly with our team during the Q&A sessions that will follow each presentation. Please visit …
The Offer is not being made, and this press release may not be distributed, directly or indirectly, in or into, nor will any tender of shares be accepted from or on behalf of shareholders in, any jurisdiction in which the making of the Offer, the distribution of this press release or …
STENOCARE A/SNASDAQ FIRST NORTH GROWTH MARKET, DENMARKTICKER: STENO STENOCARE A/S (“Stenocare” or the “Company”) announces that the Company has received a legally binding guarantee commitment of 2 mDKK from Exelity AB, securing approximately 9.9 percent of the total issue corresponding to approximately 22.0 percent of the minimum subscription. As stated in …
Stock Exchange Release 10.01.2025 at 18:30 EET/EEST FISKARS CORPORATION: ACQUISITION OF OWN SHARES 10.01.2025 Date 10.01.2025 Exchange transaction Buy Share class FSKRS Amount 2000 Average price/share 14.7915 EUR Highest price/share 14.8200 EUR Lowest price/share 14.7400 EUR Total price 29,583.00 EUR The …
ALEXANDRIA GROUP OYJ NOTIFICATION 10.01.2025 at 18:30 EET ALEXANDRIA GROUP OYJ: ACQUISITION OF OWN SHARES 10.01.2025 Date 10.01.2025 Exchange transaction Buy Share class ALEX Amount 10 Average price/share 8,7500 EUR Highest price/share 8,7500 EUR Lowest price/share 8,7500 EUR Total price 87,50 …
Read original Larvik (Norway), January 10, 2025 - In reference to the press release of January 10th issued by Greater Than, accusing ABAX of infringing upon contractually regulated intellectual property (IP) rights, ABAX categorically refutes these allegations. ABAX find it necessary to address the statements made, as these claims are …
Swedish Orphan Biovitrum AB (publ) (Sobi®) (STO:SOBI) announces today that revenue for the full year 2024 was higher than previous estimate. Full-year revenue was approximately SEK 26,000 M, representing approximately 19% growth at constant exchange rate (CER) (1). Adjusted EBITA margin (1,2) was in the mid-30s per cent of revenues. …
FIDELITY EMERGING MARKETS LIMITED (the 'Company') Legal Entity Identifier: 213800HWWQPUJ4K1GS84 TRANSACTION IN OWN SHARES The Board of the Company announces that it has bought into Treasury. Number of shares repurchased: 63,452 Date of transaction: 10 January 2025 Average share price paid per share (GBp): 693.630 Lowest share …
Transaction overview Date Trading Venue Volume Weighted average share price (NOK) Total daily cumulative transaction value (NOK) 02 January 25 OSE 25,000 28.7230 718,075 03 January 25 OSE 14,000 28.7935 403,109 06 January 25 OSE 15,000 28.8761 433,141 07 January 25 OSE 20,000 28.9190 578,380 08 January 25 OSE 14,000 29.1265 407,771 09 January 25 …
Nordea Bank AbpStock exchange release – Changes in company’s own shares10.01.2025 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 10.01.2025 completed repurchases of own shares (ISIN: FI4000297767) as follows: Trading venue (MIC Code) Number of shares Weighted average price / share, EUR* ** Total cost, EUR* ** XHEL …
